These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26441156)

  • 1. Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Cohen LS; Viguera AC; McInerney KA; Freeman MP; Sosinsky AZ; Moustafa D; Marfurt SP; Kwiatkowski MA; Murphy SK; Farrell AM; Chitayat D; Hernández-Díaz S
    Am J Psychiatry; 2016 Mar; 173(3):263-70. PubMed ID: 26441156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Viguera AC; Freeman MP; Góez-Mogollón L; Sosinsky AZ; McElheny SA; Church TR; Young AV; Caplin PS; Chitayat D; Hernández-Díaz S; Cohen LS
    J Clin Psychiatry; 2021 Aug; 82(4):. PubMed ID: 34352165
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine.
    Cohen LS; Góez-Mogollón L; Sosinsky AZ; Savella GM; Viguera AC; Chitayat D; Hernández-Díaz S; Freeman MP
    Am J Psychiatry; 2018 Dec; 175(12):1225-1231. PubMed ID: 30111186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of the National Pregnancy Registry for Atypical Antipsychotics.
    Cohen LS; Viguera AC; McInerney KA; Kwiatkowski MA; Murphy SK; Lemon EL; Hernández-Díaz S
    J Clin Psychiatry; 2015 Jul; 76(7):986-9. PubMed ID: 25939066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Freeman MP; Viguera AC; Góez-Mogollón L; Young AV; Caplin PS; McElheny SA; Church TR; Chitayat D; Hernández-Díaz S; Cohen LS
    Arch Womens Ment Health; 2021 Aug; 24(4):659-667. PubMed ID: 33710399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Major Malformations Following First-Trimester Exposure to Olanzapine: Preliminary Data From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; Freeman MP; Kobylski LA; Rossa ET; Gaccione P; Chitayat D; Hernández-Díaz S; Cohen LS
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):106-112. PubMed ID: 36825887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of atypical antipsychotics in pregnancy and maternal gestational diabetes.
    Panchaud A; Hernandez-Diaz S; Freeman MP; Viguera AC; MacDonald SC; Sosinsky AZ; Cohen LS
    J Psychiatr Res; 2017 Dec; 95():84-90. PubMed ID: 28810177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.
    McKenna K; Koren G; Tetelbaum M; Wilton L; Shakir S; Diav-Citrin O; Levinson A; Zipursky RB; Einarson A
    J Clin Psychiatry; 2005 Apr; 66(4):444-9; quiz 546. PubMed ID: 15816786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplement use by women during pregnancy: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Freeman MP; Sosinsky AZ; Moustafa D; Viguera AC; Cohen LS
    Arch Womens Ment Health; 2016 Jun; 19(3):437-41. PubMed ID: 26472040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy Outcomes Following In Utero Exposure to Second-Generation Antipsychotics: A Systematic Review and Meta-Analysis.
    Terrana N; Koren G; Pivovarov J; Etwel F; Nulman I
    J Clin Psychopharmacol; 2015 Oct; 35(5):559-65. PubMed ID: 26274044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
    Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
    Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of prenatal exposure to psychotropic drugs on neonatal outcome in infants of mothers with serious psychiatric illnesses.
    Sutter-Dallay AL; Bales M; Pambrun E; Glangeaud-Freudenthal NM; Wisner KL; Verdoux H
    J Clin Psychiatry; 2015 Jul; 76(7):967-73. PubMed ID: 25844580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US.
    Huybrechts KF; Straub L; Karlsson P; Pazzagli L; Furu K; Gissler M; Hernandez-Diaz S; Nørgaard M; Zoega H; Bateman BT; Cesta CE; Cohen JM; Leinonen MK; Reutfors J; Selmer RM; Suarez EA; Ulrichsen SP; Kieler H
    JAMA Psychiatry; 2023 Feb; 80(2):156-166. PubMed ID: 36477338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications.
    Cohen LS; Church TR; Freeman MP; Gaccione P; Caplin PS; Kobylski LA; Arakelian M; Rossa ET; Chitayat D; Hernández-Díaz S; Viguera AC
    J Womens Health (Larchmt); 2023 Apr; 32(4):452-462. PubMed ID: 36716275
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical antipsychotic use in pregnancy: a retrospective review.
    Wichman CL
    Arch Womens Ment Health; 2009 Feb; 12(1):53-7. PubMed ID: 19137446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal use of antipsychotics in early pregnancy and delivery outcome.
    Reis M; Källén B
    J Clin Psychopharmacol; 2008 Jun; 28(3):279-88. PubMed ID: 18480684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study.
    Nezvalová-Henriksen K; Spigset O; Nordeng H
    Headache; 2010 Apr; 50(4):563-75. PubMed ID: 20132339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study.
    Habermann F; Fritzsche J; Fuhlbrück F; Wacker E; Allignol A; Weber-Schoendorfer C; Meister R; Schaefer C
    J Clin Psychopharmacol; 2013 Aug; 33(4):453-62. PubMed ID: 23764684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Major Malformations in Infants After First-Trimester Exposure to Stimulants: Results From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
    Szpunar MJ; Freeman MP; Kobylski LA; Rossa ET; Gaccione P; Chitayat D; Viguera AC; Cohen LS
    J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):326-332. PubMed ID: 37235505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
    Huybrechts KF; Hernández-Díaz S; Patorno E; Desai RJ; Mogun H; Dejene SZ; Cohen JM; Panchaud A; Cohen L; Bateman BT
    JAMA Psychiatry; 2016 Sep; 73(9):938-46. PubMed ID: 27540849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.